Wall Street Ends Down As Biotechs Drop 4 Percent

US stocks ended down on Monday, led by losses in biotech shares after disappointing news from several companies including Amgen. The Nasdaq Biotech Index sank 4.1 percent, its biggest daily percentage loss since March 25, while the S&P Healthcare index, down 1.8 percent, was the biggest drag on the benchmark S&P 500 index. 

Amgen shares led the S&P 500's decline, dropping 3.3 percent to USD 162.38 after U.S. regulators said Amgen's skin cancer immunotherapy cannot be considered for an accelerated review at this time.

For Quick Trial – 8962000225 ✔

or mail us here: info@ways2capital.com

or visit http://www.ways2capital.com/

✆ - 0731-6554125 | Toll Free - 1800-3010-2007